Table 2 Incidence of VAP (percentage of total patients and number of VAP episodes/1000 ventilator days)
Incidence VAP | Incidence VAP | |||||
|---|---|---|---|---|---|---|
Author, year | Intervention group (percentage of patients [n = patients]) | Control group (percentage of patients [n = patients]) | Relative risk (95% CI) | Intervention group (VAP episodes/1000 ventilator days) | Control group (VAP episodes/1000 ventilator days) | Relative risk |
Morrow et al., 2010 [29] | 19.1% (n = 68) | 40.0% (n = 70) | 0.5 (0.3 to 0.8) | |||
Rongrungruang et al., 2015 [32] | 24.0% (n = 75) | 29.3% (n = 75) | 0.8 (0.3 to 0.6) | 22.6 | 30.2 | 0.8 |
Klarin et al., 2008 [28] | 4.3% (n = 23) | 14.3% (n = 21) | 0.3 (0.0 to 2.7) | |||
Knight et al., 2009 [33] | 9.0% (n = 130) | 13.0% (n = 129) | 0.7 (0.4 to 1.4) | 13.0 | 14.6 | 0.9 |
Forestier et al., 2008 [27] | 23.5% (n = 102) | 22.6% (n = 106) | 1.0 (0.6 to 1.7) | |||
Barraud et al., 2010 [26] | 26.4% (n = 87) | 18.7% (n = 80) | 1.4 (0.8 to 2.5) | 23.0 | 14.6 | 1.6 |
Zeng et al., 2016 [31] | 36.4% (n = 118) | 50.4% (n = 117) | 0.7 (0.5 to 1.0) | |||